Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature Reviews Neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrneurol.2016.167PMID 27886201
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poor specificity of urinary cryptococcal antigen testing

  2018cited by this paper
• The way forward

  2018cited by this paper
• Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis.

  2016cited by this paper
• Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis

  2016cited by this paper
• Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections

  2016cited by this paper
• Efficacy of Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis: an open-label dose-ranging study

  2016cited by this paper
• A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis

  2016cited by this paper
• Bladder Management With Epidural Anesthesia During Labor: A Randomized Controlled Trial

  2015cited by this paper
• Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study

  2015cited by this paper
• Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia.

  2015cited by this paper
• Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.

  2015cited by this paper
• Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu‐Natal

  2015cited by this paper
• Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis

  2015cited by this paper
• Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii

  2015cited by this paper
• Dramatic Improvement of Severe Cryptococcosis‐Induced Immune Reconstitution Syndrome With Adalimumab in a Renal Transplant Recipient

  2015cited by this paper
• Cryptococcus neoformans Host Adaptation: Toward Biological Evidence of Dormancy

  2015cited by this paper
• Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial

  2015cited by this paper
• Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex.

  2015cited by this paper
• Cerebrospinal Fluid Cytokine Profiles Predict Risk of Early Mortality and Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis

  2015cited by this paper
• Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

  2015cited by this paper
• Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study

  2015cited by this paper
• Cryptococcus: from environmental saprophyte to global pathogen

  2015cited by this paper
• Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitis.

  2015cited by this paper
• Pitfalls in Serological Diagnosis of Cryptococcus gattii Infections.

  2015cited by this paper
• Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis

  2015cited by this paper
• Epidemiology of meningitis in an HIV-infected Ugandan cohort.

  2015cited by this paper
• AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial

  2015cited by this paper
• Performance of the Cryptococcal Antigen Lateral Flow Assay in Non-HIV-Related Cryptococcosis

  2015cited by this paper
• A Prospective Study of Mortality from Cryptococcal Meningitis following Treatment Induction with 1200mg Oral Fluconazole in Blantyre, Malawi

  2014cited by this paper
• Prospective Cohort Study

  2014cited by this paper
• GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.

  2014cited by this paper
• Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

  2014cited by this paper
• a case report and review of the

  2014cited by this paper
• The tools for virulence of Cryptococcus neoformans.

  2014cited by this paper
• Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days

  2014cited by this paper
• HEMATOPOIESIS AND STEM CELLS GATA 2 de fi ciency : a protean disorder of hematopoiesis , lymphatics , and immunity

  2014cited by this paper
• Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.

  2014cited by this paper
• The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis

  2014cited by this paper
• Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo

  2014cited by this paper
• Bacterial Meningitis in Malawian Adults, Adolescents, and Children During the Era of Antiretroviral Scale-up and Haemophilus influenzae Type b Vaccination, 2000–2012

  2014cited by this paper
• Cryptococcus gattii in North American Pacific Northwest: Whole-Population Genome Analysis Provides Insights into Species Evolution and Dispersal

  2014cited by this paper
• Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome

  2014cited by this paper
• Sapronosis: a distinctive type of infectious agent.

  2014cited by this paper
• Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies Are a Risk Factor for Central Nervous System Infection by Cryptococcus gattii in Otherwise Immunocompetent Patients

  2014cited by this paper
• A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis following Treatment Induction with 800 mg Oral Fluconazole in Blantyre, Malawi

  2013cited by this paper
• Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy.

  2013cited by this paper
• Combination antifungal therapy for cryptococcal meningitis.

  2013cited by this paper
• Anti–GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis

  2013cited by this paper
• Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa

  2013cited by this paper
• Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.

  2013cited by this paper
• Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.

  2013cited by this paper
• Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases

  2013cited by this paper
• The Phenotype of the Cryptococcus-Specific CD4+ Memory T-Cell Response Is Associated With Disease Severity and Outcome in HIV-Associated Cryptococcal Meningitis

  2013cited by this paper
• A suicide risk screening scale for HIV- infected persons in the immediate post- diagnosis period

  2013cited by this paper
• An Open Label Randomised Controlled Trial of Probiotics for Primary Prophylaxis of Hepatic Encephalopathy in Patients with Cirrhosis

  2013cited by this paper
• Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

  2013cited by this paper
• Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal

  2013cited by this paper
• Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update

  2013cited by this paper
• Epidemiology of Cryptococcal Meningitis in the US: 1997–2009

  2013cited by this paper
• Combination antifungal therapy for cryptococcal meningitis.

  2013cited by this paper
• Cryptococcal immune reconstitution inflammatory syndrome

  2013cited by this paper
• Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries.

  2013cited by this paper
• Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases.

  2013cited by this paper
• Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status

  2013cited by this paper
• Cost-Effective Diagnostic Checklists for Meningitis in Resource-Limited Settings

  2013cited by this paper
• Cryptococcus gattii Induces a Cytokine Pattern That Is Distinct from Other Cryptococcal Species

  2013cited by this paper
• Early Clinical and Subclinical Visual Evoked Potential and Humphrey's Visual Field Defects in Cryptococcal Meningitis

  2012cited by this paper
• Emerging fungal threats to animal, plant and ecosystem health

  2012cited by this paper
• A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia.

  2012cited by this paper
• A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis

  2012cited by this paper
• How I treat cryptococcosis in organ transplant recipients.

  2012cited by this paper
• Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis.

  2012cited by this paper
• Association of Fcγ Receptor IIB Polymorphism with Cryptococcal Meningitis in HIV-Uninfected Chinese Patients

  2012cited by this paper
• Cryptococcus.

  2012cited by this paper
• Phased implementation of screening for cryptococcal disease in South Africa.

  2012cited by this paper
• Adjunctive interferon-&ggr; immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial

  2012cited by this paper
• Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death.

  2012cited by this paper
• Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.

  2012cited by this paper
• Adult-onset immunodeficiency in Thailand and Taiwan.

  2012cited by this paper
• A Systematic Review and Meta-analysis

  2011cited by this paper
• Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

  2011cited by this paper
• Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.

  2011cited by this paper
• Monoclonal Antibodies Specific for Immunorecessive Epitopes of Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Reduce Serotype Bias in an Immunoassay for Cryptococcal Antigen

  2011cited by this paper
• Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997-2007.

  2010cited by this paper
• In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and C. neoformans infection in Gaborone, Botswana.

  2010cited by this paper
• Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.

  2010cited by this paper
• Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions.

  2010cited by this paper
• Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

  2010cited by this paper
• Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome.

  2010cited by this paper
• Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.

  2010cited by this paper
• Pulmonary cryptococcosis misdiagnosed as smear-negative pulmonary tuberculosis with fatal consequences.

  2010cited by this paper
• Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS)

  2010cited by this paper
• Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

  2010cited by this paper
• Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study

  2010cited by this paper
• Immunopathology and Infectious Diseases Pulmonary Infection with an Interferon-- Producing Cryptococcus neoformans Strain Results in Classical Macrophage Activation and Protection

  2010cited by this paper
• Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.

  2010cited by this paper
• Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure

  2010cited by this paper
• Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

  2010cited by this paper
• No evidence of differential effects of SFA, MUFA or PUFA on post-ingestive satiety and energy intake: a randomised trial of fatty acid saturation

  2010cited by this paper
• Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.

  2010cited by this paper

• Strain-specific variation in virulence and host-immune modulation across the Cryptococcus gattii species complex.

  2026cites this paper
• Comparison of the Efficacy and Safety of Different Antifungal Regimen Combinations in Non-HIV and Non-transplant Cryptococcal Meningitis Patients with High Cryptococcal Count

  2026influential citation
• Contribution of fungal diseases to the U.S. chronic disease burden

  2026cites this paper
• Activity and Safety Optimization of Mesoricin: A Dual-Domain Antifungal Peptide from Mesorhizobium sp.

  2025cites this paper
• Clinicopathological Features, Treatment Outcome, and the Cryptococcal Antigen Latex Agglutination System Titer in Feline Cryptococcosis Treated with Amphotericin B and Fluconazole

  2025influential citation
• Phenotypic landscape of an invasive fungal pathogen reveals its unique biology.

  2025cites this paper
• Cryptococcal Meningitis in an HIV-Negative, Lymphoma Survivor: A Case Report of an Uncommon Dual Pathology

  2025cites this paper
• Pediatric non-congenital central nervous system infections: role of imaging in the emergency department

  2025cites this paper
• Speckled-egg staining appearance of cryptococcal osteomyelitis in an immunocompetent patient

  2025cites this paper
• Asymptomatic Cryptococcal Antigenemia: A Multi-clinic Cross-Sectional Study on the Prevalence, Associated Factors and Predictors of Three-Month Outcomes Among Antiretroviral-Naïve and Antiretroviral-Experienced HIV Patients in Dar es Salaam, Tanzania

  2025cites this paper
• CsDETC: detection and counting of small target Cryptococcus spp.

  2025cites this paper
• Cryptococcosis in kidney transplant recipients: Pathogenesis, clinical challenges, and evolving therapeutic strategies.

  2025cites this paper
• Internuclear Ophthalmoplegia as Rare Initial Presentation Cryptococcal Meningitis A Case Report and Review of Literature

  2025cites this paper
• Foxp3+ Regulatory T Cells Restrain Th1 Response Shielding the Brain from Lethal Inflammatory Damage during Cryptococcal Meningoencephalitis

  2025cites this paper
• Combination of isobavachalcone and amphotericin B has antifungal effect against Cryptococcus neoformans and protects host tissue damage by inhibiting ferroptosis

  2025cites this paper
• Non-acquired immunodeficiency syndrome-related cryptococcal meningitis with recurrent acute stroke: A case report

  2025influential citation
• Lead Optimization and Target Identification of Carboline Antifungal Agents.

  2025cites this paper
• Research progress on immunometabolism and gut microbiota in cryptococcal meningitis: mechanisms and therapeutic implications

  2025cites this paper
• Longitudinally Extensive Transverse Myelitis and Vasculitis by Cryptococcosis in a Non-HIV Patient: A Case Report

  2025cites this paper
• An Atypical Presentation of Culture-Negative Cryptococcal Meningitis in an Immunocompetent Host With Prior Stroke: A Case Report

  2025cites this paper
• CNS infections in patients with hematological or oncological diseases (including cellular therapies) - 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

  2025cites this paper
• A Lethal Case of Cryptococcal Meningitis in an Apparently Immunocompetent Patient: A Case Report Highlighting Diagnostic Pitfalls and Therapeutic Challenges

  2025cites this paper
• Point-of-Need Test of Cryptococcus Utilizing Aggregation-induced Emission-based Lateral Flow Immunoassay.

  2025cites this paper
• The Pain is in the Brain with the Sugar-Coated Killer.

  2025cites this paper
• Cytokine dynamics in the blood and cerebrospinal fluid of HIV/AIDS patients with cryptococcal meningitis receiving antifungal therapy

  2025cites this paper
• Unusual Presentation of Cryptococcal Meningitis in an Immunocompetent Patient on Hemodialysis

  2025cites this paper
• BEYOND HIV-ASSOCIATED ANEMIA: EXPLORING THE CONSEQUENCES OF REPEATED BLOOD TRANSFUSIONS IN HIV CARE

  2025cites this paper
• Comparison of mNGS with conventional methods for diagnosis of cryptococcal meningitis: a retrospective study

  2025cites this paper
• Cerebral Venous Thrombosis in Previously Healthy Patients with Cryptococcal Meningitis.

  2025cites this paper
• Cryptococcal Meningoencephalitis With Herpes Zoster Coinfection in a Retrovirus-Positive Adolescent Male With a Normal CD4 Count: A Rare Case

  2025cites this paper
• The Hidden Fortress: A Comprehensive Review of Fungal Biofilms with Emphasis on Cryptococcus neoformans

  2025influential citation
• In vitro susceptibility of C. neoformans isolates against FLU from HIV-negative CM patients in Guangdong, China.

  2025cites this paper
• Optical Coherence Tomography Findings of Macula and Neural Changes in Cryptococcal Meningitis.

  2025cites this paper
• A series of cryptococcal meningitis cases

  2025cites this paper
• Evaluating clinical outcome in non-HIV associated cryptococcal meningitis with negative CSF culture using microscopic quantitative cryptococcal counting.

  2025cites this paper
• Evaluation of the MAGLUMI HIV Ab/Ag combi test for the detection of HIV infection

  2024cites this paper
• Phenotypic landscape of a fungal meningitis pathogen reveals its unique biology

  2024cites this paper
• Brainstem cryptococcoma.

  2024cites this paper
• Disseminated cryptococcosis in a child with liver transplantation: a case report.

  2024cites this paper
• A rare case of cryptococcal meningitis with infarction of the splenium of the corpus callosum in an immunocompetent patient: A case report

  2024cites this paper
• Global research trends and hotspots on human intestinal fungi and health: a bibliometric visualization study

  2024cites this paper
• Inhibition of host 5-lipoxygenase reduces overexuberant inflammatory responses and mortality associated with Cryptococcus meningoencephalitis

  2024influential citation
• Improvement of the Facial and Dental Esthetics With Surgery-Only Approach

  2024influential citation
• Cnes2b Regulates Host Resistance, Inflammatory Responses and Tissue Damage Following Cryptococcus deneoformans Infection

  2024cites this paper
• MRI changes in cryptococcal meningoencephalitis exacerbated by antifungal treatment due to post-infectious inflammatory syndrome: A case report

  2024cites this paper
• Case report: A diabetic patient with cryptococcal meningoencephalitis complicated by post-infectious inflammatory response syndrome

  2024influential citation
• Cerebrospinal Fluid Lactate Levels as a Prognostic Indicator in Patients With Cryptococcal Meningitis Who Are HIV Negative: A Retrospective Cohort Study

  2024influential citation
• The role of lipids in regulating macrophage antifungal immunity

  2024cites this paper
• Evento vascular cerebral occipital secundario a criptococosis meníngea

  2024cites this paper
• Ultrasensitive Aptamer-Based Electrochemical Nanobiosensor in Diagnosis of Prostate Cancer Using 2D:2D Reduced Graphene Oxide/graphitic Carbon Nitride decorated with Au Nanoparticles

  2024cites this paper
• With age comes resilience: how mitochondrial modulation drives age-associated fluconazole tolerance in Cryptococcus neoformans

  2024cites this paper
• Reframing the clinical phenotype and management of cryptococcal meningitis

  2024cites this paper
• A Patient With Cryptococcal Meningitis Accompanied With Acute Intracranial Hypertension Treated by Ventricular Abdominal-wall Drainage

  2024cites this paper
• Quantitative MRI of a Cerebral Cryptococcoma Mouse Model for In Vivo Distinction between Different Cryptococcal Molecular Types

  2024cites this paper
• Cryptococcal Meningitis in an Immunocompetent Patient With Underlying Risk Factors

  2024cites this paper
• The pathobiology of human fungal infections

  2024cites this paper
• Characteristics of HIV-associated cryptococcal meningitis in a tertiary Chilean hospital: An observational retrospective study.

  2024cites this paper
• HIV and Cryptococcal Meningitis: A Case Report

  2024influential citation
• Criptococose sistêmica atípica em felinos causada por Cryptococcus gattii VGII

  2024cites this paper
• Cryptococcal Meningitis in an HCV-Positive and IVDU- and HIV-Negative Patient: A Case Report and Literature Review

  2024cites this paper
• Utility of handheld non-mydriatic fundoscopy in a case of bilateral, reversible vision loss in an advanced HIV patient with cryptococcal meningitis in Sub-Saharan Africa

  2024cites this paper
• PACIENTE IMUNOCOMPETENTE PORTADORA DE CRIPTOCOCOSE DISSEMINADA:UM RELATO DE CASO

  2024cites this paper
• Influence of the agrochemical benomyl on Cryptococcus gattii-plant interaction in vitro and in vivo

  2024cites this paper
• Presence of Epstein-Barr virus in cerebrospinal fluid is associated with increased mortality in HIV-negative cryptococcal meningitis.

  2024cites this paper
• Establishment and methodological evaluation of a rapid detection method for Cryptococcus neoformans and Cryptococcus gattii species complexes based on CRISPR-Cas12a technology.

  2024cites this paper
• Psychological features of HIV-infected patients depending on the stage of the disease

  2024cites this paper
• Cryptococcal meningitis presenting as simple headache in early adulthood HIV-infected patient: A case report

  2024cites this paper
• Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system

  2024cites this paper
• Autochthonous Cryptococcus gattii genotype VGIIb infection in a Japanese patient with anti-granulocyte-macrophage colony-stimulating factor antibodies.

  2024cites this paper
• Achieving Resilience in Aging: How Mitochondrial Modulation Drives Age-associated Fluconazole Tolerance in Cryptococcus neoformans

  2024cites this paper
• The Role of Oxidative Stress in TB Meningitis and Therapeutic Options

  2024cites this paper
• Meningitis criptocócica asociada a hidrocefalia en un paciente inmunocompetente

  2024cites this paper
• CCCerebral cryptococcosis regarding two clinical cases and bibliographic review

  2024cites this paper
• Construction and validation of a nomogram model to predict the poor prognosis in patients with pulmonary cryptococcosis

  2024cites this paper
• Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines

  2024cites this paper
• Pulmonary cryptococcosis complicated with pulmonary aspergillosis: a series of studies and a literature review

  2024cites this paper
• Epidemiology and etiology of community-acquired CNS infections in Iran: a narrative review

  2024cites this paper
• Pediatric Cryptococcosis

  2024cites this paper
• Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study

  2024cites this paper
• Idiopathic eosinophilia complicated with cryptococcal meningitis: a case report

  2024cites this paper
• Comparing the Performance of Two Cryptococcal Antigen Detection Tests: Chemiluminescence vs Colloidal Gold Methods

  2024cites this paper
• A nomogram to predict cryptococcal meningitis in patients with pulmonary cryptococcosis

  2024cites this paper
• Batf3-dependent orchestration of the robust Th1 responses and fungal control during cryptococcal infection, the role of cDC1

  2024cites this paper
• Trends in Clinico-Epidemiological Profile and Outcomes of Patients with HIV-Associated Cryptococcal Meningitis in Shanghai, China, 2013–2023

  2024cites this paper
• Macropinocytosis as a potential mechanism driving neurotropism of Cryptococcus neoformans

  2023cites this paper
• Multiple Umbilicated Papules on the Face.

  2023cites this paper
• Voriconazole plus flucytosine is not superior to amphotericin B deoxycholate plus flucytosine as an induction regimen for cryptococcal meningitis treatment

  2023cites this paper
• Development and validation of a machine learning model to predict prognosis in HIV-negative cryptococcal meningitis patients: a multicenter study

  2023cites this paper
• Microglia are not protective against cryptococcal meningitis

  2023cites this paper
• MULTI-LOCUS SEQUENCE TYPING AND PHYLOGENETICS OF CRYPTOCOCCUS NEOFORMANS AD HYBRIDS.

  2023cites this paper
• Single high-dose amphotericin B for cryptococcal meningitis: First Indian experience.

  2023cites this paper
• Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen

  2023cites this paper
• How metals fuel fungal virulence, yet promote anti-fungal immunity

  2023cites this paper
• MENINGEAL SYNDROME: DIAGNOSTIC ALGORITHM, TREATMENT TACTICS

  2023cites this paper
• Predictive Performance of Scoring Systems for Mortality Risk in Patients with Cryptococcemia: An Observational Study

  2023cites this paper
• Emerging Roles of (1→3)-β-D-glucan in Cerebrospinal Fluid for Detection and Therapeutic Monitoring of Invasive Fungal Diseases of the Central Nervous System.

  2023cites this paper
• Akurasi Pemeriksaan Lateral Flow Assay Cryptococcal Antigen Serum Dalam Penegakan Diagnosis Meningitis Kriptokokus Lateral Flow Assay Cryptococcal Antigen Examination Accuracy In Establishing Diagnosis Of Cryptococcal Meningitis

  2023influential citation
• Race and ethnicity: Risk factors for fungal infections?

  2023cites this paper
• Clinical Features of Cryptococcal Meningoencephalitis in HIV-Positive and -Negative Patients in a Resource-Limited Setting

  2023cites this paper
• The incidences and clinical outcomes of cryptococcosis in Taiwan: A nationwide, population-based study, 2002–2015

  2023cites this paper